Rurioctocog alfa pegol

Chemical formula: C₂₁H₄₀N₄O₁₀  Molecular mass: 508.274 g/mol 

Therapeutic indications

Rurioctocog alfa pegol is indicated for:

Haemophilia A (congenital factor VIII deficiency)

Population group: only adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Treatment and prophylaxis of bleeding in patients 12 years and above with haemophilia A (congenital factor VIII deficiency).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.